Abstrakt
The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
Bidragets oversatte titel | Bacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterielle infektioner |
---|---|
Originalsprog | Engelsk |
IPC | A61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04 |
Patentnummer | WO 2108/234301 A1 |
Journaliseringsdato | 27/12/2018 |
Land | Danmark |
Prioritetsdato | 19/06/2017 |
Prioritetsnummer | EP20170176612 |
Status | Udgivet - 27. dec. 2018 |